Cas 1239016-07-9,N<sub>1</sub>-{5-[(naphthalene-2-yloxy)methyl]-1,3,4-oxadiazol-2-yl}-N<sub>4</sub>-[1-(4-chlorophenyl)ethanone]semicarbazone

1239016-07-9

Post Buying Request

Basic information

Product Name: N₁-{5-[(naphthalene-2-yloxy)methyl]-1,3,4-oxadiazol-2-yl}-N₄-[1-(4-chlorophenyl)ethanone]semicarbazone
Synonyms:
CAS NO:1239016-07-9
Molecular Formula:
Molecular Weight: 435.87
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N₁-{5-[(naphthalene-2-yloxy)methyl]-1,3,4-oxadiazol-2-yl}-N₄-[1-(4-chlorophenyl)ethanone]semicarbazone(CAS DataBase Reference)
NIST Chemistry Reference: N₁-{5-[(naphthalene-2-yloxy)methyl]-1,3,4-oxadiazol-2-yl}-N₄-[1-(4-chlorophenyl)ethanone]semicarbazone(1239016-07-9)
EPA Substance Registry System: N₁-{5-[(naphthalene-2-yloxy)methyl]-1,3,4-oxadiazol-2-yl}-N₄-[1-(4-chlorophenyl)ethanone]semicarbazone(1239016-07-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1239016-07-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1239016-07-9 Suppliers

Recommended suppliers

1239016-07-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1239016-07-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,9,0,1 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1239016-07:
(9*1)+(8*2)+(7*3)+(6*9)+(5*0)+(4*1)+(3*6)+(2*0)+(1*7)=129
129 % 10 = 9
So 1239016-07-9 is a valid CAS Registry Number.

1239016-07-9Upstream product

1239016-07-9Downstream Products

1239016-07-9Relevant academic research and scientific papers

Novel semicarbazones based 2,5-disubstituted-1,3,4-oxadiazoles: One more step towards establishing four binding site pharmacophoric model hypothesis for anticonvulsant activity

Rajak, Harish,Deshmukh, Ravitas,Veerasamy, Ravichandran,Sharma, Ajay Kumar,Mishra, Pradeep,Kharya, Murli Dhar

supporting information; experimental part, p. 4168 - 4172 (2010/08/20)

A series of novel N1-{5-[(naphthalene-2-yloxy)methyl]-1,3,4-oxadiazol-2-yl}-N4-(4-substitutedbenzaldehyde)-semicarbazone, N1-{5-[(naphthalene-2-yloxy)methyl]-1,3,4-oxadiazol-2-yl}-N4-[1-(4-substitutedphenyl)etha

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1239016-07-9